Joshua S. James
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joshua S. James has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Yizhi Cai
Manchester Institute of Biotechnology, University of Manchester, Manchester, UK
3 shared publications - Déborah Tribouillard-Tanvier
Univ. Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France
2 shared publications - Kewin Gombeau
Manchester Institute of Biotechnology, University of Manchester , 131 Princess Street, M1 7DN, Manchester
2 shared publications - Raymond Wan
Manchester Institute of Biotechnology, University of Manchester , 131 Princess Street, M1 7DN, Manchester
2 shared publications - Junbiao Dai
Shenzhen Key Laboratory of Synthetic Genomics, Guangdong Provincial Key Laboratory of Synthetic Genomics, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
1 shared publication - Wei Leong Chew
Genome Institute of Singapore, Agency for Science, Technology and Research, 60 Biopolis Street, Singapore 138672, Singapore
1 shared publication
Latest Publications
- Open Access
- 13 October 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (19)
TargetMITO: a rule-based model for generating functional synthetic mitochondrial targeting sequences in yeast
Mitochondria are essential organelles containing their own genomes, encoding a few proteins essential for energy production. Most of the mitochondrial proteins are nucleus-encoded, translated as precursors in the cytosol, with a large fraction of these precursors properly addressed by an N-terminal mitochondrial targeting sequence (MTS). These MTS share common features but no consensus sequence can explain their functionality nor the precursors-specific determinants of mitochondrial import. To help understand this mechanism, we created a simple computational model to generate functional synthetic MTS while maintaining a tight control on the design parameters. Using the budding yeast, we demonstrated the presence of precursors-specific import capabilities in addressing artificially nucleus-relocated OXPHOS proteins. Our research confirms the existence of cargo-dependent functional compatibilities and takes us one step closer towards improving gene therapy-based treatment of mitochondrial diseases.
- 13 October 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (19)
Open AccessTargetMITO: a rule-based model for generating functional synthetic mitochondrial targeting sequences in yeast
Mitochondria are essential organelles containing their own genomes, encoding a few proteins essential for energy production. Most of the mitochondrial proteins are nucleus-encoded, translated as precursors in the cytosol, with a large fraction of these precursors properly addressed by an N-terminal mitochondrial targeting sequence (MTS). These MTS share common features but no consensus sequence can explain their functionality nor the precursors-specific determinants of mitochondrial import. To help understand this mechanism, we created a simple computational model to generate functional synthetic MTS while maintaining a tight control on the design parameters. Using the budding yeast, we demonstrated the presence of precursors-specific import capabilities in addressing artificially nucleus-relocated OXPHOS proteins. Our research confirms the existence of cargo-dependent functional compatibilities and takes us one step closer towards improving gene therapy-based treatment of mitochondrial diseases.
- Open Access
TargetMITO: A rule-based model for generating highly functional synthetic mitochondrial targeting sequence in yeast
Mitochondria are essential organelles containing their own genomes, encoding a few proteins essential for energy production. Most of the mitochondrial proteins are nucleus-encoded, translated as precursors in the cytoplasm, with a large fraction of these precursors properly addressed by an N-terminal mitochondrial targeting sequence (MTS). These MTS share common features but no consensus sequence can explain their functionality nor the precursors-specific determinants of mitochondrial import. To decipher this mechanism, we created a simple computational model to generate highly functional synthetic MTS while maintaining a tight control on the design parameters. Using the budding yeast, we demonstrated the presence of precursors-specific signatures in addressing artificially nucleus-relocated OXPHOS proteins. We also show the ability of six promising candidate synthetic MTS to address a fluorescent reporter to human mitochondria cells. Our research work confirms the uniqueness of the MTS-passenger protein synergy and takes us one step closer towards improving gene therapy-based treatment of mitochondrial diseases. Graphical
Open AccessTargetMITO: A rule-based model for generating highly functional synthetic mitochondrial targeting sequence in yeast
Mitochondria are essential organelles containing their own genomes, encoding a few proteins essential for energy production. Most of the mitochondrial proteins are nucleus-encoded, translated as precursors in the cytoplasm, with a large fraction of these precursors properly addressed by an N-terminal mitochondrial targeting sequence (MTS). These MTS share common features but no consensus sequence can explain their functionality nor the precursors-specific determinants of mitochondrial import. To decipher this mechanism, we created a simple computational model to generate highly functional synthetic MTS while maintaining a tight control on the design parameters. Using the budding yeast, we demonstrated the presence of precursors-specific signatures in addressing artificially nucleus-relocated OXPHOS proteins. We also show the ability of six promising candidate synthetic MTS to address a fluorescent reporter to human mitochondria cells. Our research work confirms the uniqueness of the MTS-passenger protein synergy and takes us one step closer towards improving gene therapy-based treatment of mitochondrial diseases. Graphical
- 6 November 2024
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 26 (5) , 298-319
The design and engineering of synthetic genomes
Synthetic genomics seeks to design and construct entire genomes to mechanistically dissect fundamental questions of genome function and to engineer organisms for diverse applications, including bioproduction of high-value chemicals and biologics, advanced cell therapies, and stress-tolerant crops. Recent progress has been fuelled by advancements in DNA synthesis, assembly, delivery and editing. Computational innovations, such as the use of artificial intelligence to provide prediction of function, also provide increasing capabilities to guide synthetic genome design and construction. However, translating synthetic genome-scale projects from idea to implementation remains highly complex. Here, we aim to streamline this implementation process by comprehensively reviewing the strategies for design, construction, delivery, debugging and tailoring of synthetic genomes as well as their potential applications.
- 6 November 2024
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 26 (5) , 298-319
The design and engineering of synthetic genomes
Synthetic genomics seeks to design and construct entire genomes to mechanistically dissect fundamental questions of genome function and to engineer organisms for diverse applications, including bioproduction of high-value chemicals and biologics, advanced cell therapies, and stress-tolerant crops. Recent progress has been fuelled by advancements in DNA synthesis, assembly, delivery and editing. Computational innovations, such as the use of artificial intelligence to provide prediction of function, also provide increasing capabilities to guide synthetic genome design and construction. However, translating synthetic genome-scale projects from idea to implementation remains highly complex. Here, we aim to streamline this implementation process by comprehensively reviewing the strategies for design, construction, delivery, debugging and tailoring of synthetic genomes as well as their potential applications.